SCHEMBL3774679

SCHEMBL3774679

ClCCCC1CNCCO1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 14/20 0.40
SLC6A4 P31645 12/20 0.40
SLC6A3 Q01959 10/20 0.40
HTR2A P28223 4/20 0.40
HTR2B P41595 2/20 0.40
ADRB2 P07550 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA2C P18825 1/20 0.40
HRH1 P35367 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
HTR3A P46098 1/20 0.35
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4938994 0.98 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL250057 0.88
SCHEMBL11652607 0.87 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
Hydrochloric Acid SCHEMBL74240 0.86 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL1746181 0.83 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL3984484 0.80 EPHX1 (0.48) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL3867317 0.80 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL20929877 0.80 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL18531916 0.80 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL1260402 0.80 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3HTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174938-A 4-indole-2-aminopyrimidine compounds and application thereof 浙江工业大学 2021-01-05 CN claimed
CN-107586279-A A kind of new synthetic method of Gefitinib 江苏正大清江制药有限公司 2018-01-16 CN claimed
CN-105503749-A Synthetic method of 4-(3-chlorine-4-fluorophenyl)-7-methoxyl-6-[3-(4-morpholinyl) propoxy] quinazoline NANJING EAST SUNSCREEN PHARMACEUTICAL CO LTD 2016-04-20 CN claimed
CN-102675246-B Preparation method of pramoxine hydrochloride JINAN CHENGHUI SHUANGDA CHEMICAL CO LTD 2014-04-23 CN claimed
US-6384031-B1 None US disclosed
US-6392040-B1 None US disclosed
CN-114685456-B 2, 5-diketopiperazine compound derivative, preparation method thereof, pharmaceutical composition and application thereof 大连万众益生大健康有限公司 2023-10-10 CN disclosed
CN-113264889-B Method suitable for industrial production and preparation of gefitinib 广西师范大学 2023-08-08 CN disclosed
CN-113264889-B Method suitable for industrial production and preparation of gefitinib 广西师范大学 2023-08-08 CN disclosed
WO-2023088420-A1 1H-BENZO[B]AZEPIN-2(3H)-ONE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER Chengdu Anticancer Bioscience, Ltd. (CN) 2023-05-25 WO disclosed
CN-112574177-B Pyrimidine derivatives and application thereof in preparing antitumor drugs 陕西师范大学 2023-01-31 CN disclosed
CN-113264978-B Novel molecular targeting anti-tumor aza steroid derivative based on lipotoxicity and preparation method and application thereof 重庆医科大学 2023-01-31 CN disclosed
WO-2001044245-A1 SACCHARIN DERIVATIVES AS ORALLY ACTIVE ELASTASE INHIBITORS SANOFI-SYNTHELABO (FR) 2001-06-21 WO disclosed
CN-1278255-A Cyclopentene derivatives useful as antagonists of the motilin receptor ORTHO MCNEIL PHARMACEUTICAL CO (US) 2000-12-27 CN disclosed
WO-2000068201-A1 QUINOLINE DERIVATIVES AS INHIBITORS OF MEK ENZYMES ASTRAZENECA AB (SE) 2000-11-16 WO disclosed
EP-1027342-A1 CYCLOPENTENE DERIVATIVES USEFUL AS ANTAGONISTS OF THE MOTILIN RECEPTOR Ortho-Mcneil Pharmaceutical, Inc. (US) 2000-08-16 EP disclosed
US-5972939-A Cyclopentene derivatives useful as antagonists of the motilin receptor ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-10-26 US disclosed
WO-1999021846-A1 CYCLOPENTENE DERIVATIVES USEFUL AS ANTAGONISTS OF THE MOTILIN RECEPTOR ORTHO-MCNEIL PHARMACEUTICAL INC. (US) 1999-05-06 WO disclosed
EP-0758315-A1 NOVEL HYDROXIMIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME BIOREX KUTATO ES FEJLESZTÖ RT. (HU) 1997-02-19 EP disclosed
WO-1995030649-A1 NOVEL HYDROXIMIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME BIOREX KUTATÓ ÉS FEJLESZTO^' RT. (HU) 1995-11-16 WO disclosed